{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:42:16Z","timestamp":1788496936096,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI77767"],"award-info":[{"award-number":["AI77767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSTO-CBD"},{"DOI":"10.13039\/100000774","name":"DTRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.antiviral.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T07:18:27Z","timestamp":1530688707000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics"],"prefix":"10.1016","volume":"157","author":[{"given":"Adam","family":"Schafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.antiviral.2018.07.003_bib1","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2018.07.003_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1986.tb02946.x","article-title":"Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration","volume":"26","author":"Blyden","year":"1986","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.antiviral.2018.07.003_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J. Virol."},{"issue":"7364","key":"10.1016\/j.antiviral.2018.07.003_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter niemann-pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.07.003_bib5","unstructured":"Carson, S., Lee, N., & Thakurta, S. (2010). No title.NBK50558 [bookaccession]."},{"issue":"5728","key":"10.1016\/j.antiviral.2018.07.003_bib6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science (New York, N.Y.)"},{"issue":"19","key":"10.1016\/j.antiviral.2018.07.003_bib7","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of ebola and marburg virus entry by G protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.07.003_bib8","series-title":"Identification of a Coumarin-based Antihistamine-like Small Molecule as an Anti-filoviral Entry Inhibitor","author":"Cheng","year":"2017"},{"issue":"7364","key":"10.1016\/j.antiviral.2018.07.003_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal niemann-pick C1 is essential for ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.07.003_bib11","doi-asserted-by":"crossref","first-page":"41226","DOI":"10.1038\/srep41226","article-title":"Selective inhibition of ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"9768","key":"10.1016\/j.antiviral.2018.07.003_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.antiviral.2018.07.003_bib13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/jps.2600681134","article-title":"Sensitive assay for determination of hydroxyzine in plasma and its human pharmacokinetics","volume":"68","author":"Fouda","year":"1979","journal-title":"J. Pharmaceut. Sci."},{"issue":"21","key":"10.1016\/j.antiviral.2018.07.003_bib14","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural insights into the niemann-pick C1 (NPC1)-mediated cholesterol transfer and ebola infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.antiviral.2018.07.003_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.06.026","article-title":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus","volume":"340","author":"Gramberg","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2018.07.003_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jat\/8.2.97","article-title":"Blood and urine concentrations of cyclizine by nitrogen-phosphorus gas-liquid chromatography","volume":"8","author":"Griffin","year":"1984","journal-title":"J. Anal. Toxicol."},{"issue":"190","key":"10.1016\/j.antiviral.2018.07.003_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.antiviral.2018.07.003_bib19","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2018.07.003_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00637624","article-title":"Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man","volume":"21","author":"Labout","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.07.003_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00042737-199610001-00002","article-title":"The changing role of H2-receptor antagonists in acid-related diseases","volume":"8","author":"Lamers","year":"1996","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2018.07.003_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11373-005-9053-7","article-title":"Antimuscarinic actions of antihistamines on the heart","volume":"13","author":"Liu","year":"2006","journal-title":"J. Biomed. Sci."},{"issue":"8","key":"10.1016\/j.antiviral.2018.07.003_bib24","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of ebola virus GP1 in viral entry","volume":"79","author":"Manicassamy","year":"2005","journal-title":"J. Virol."},{"issue":"14","key":"10.1016\/j.antiviral.2018.07.003_bib25","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1128\/JVI.00136-12","article-title":"Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection","volume":"86","author":"Miller","year":"2012","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib26","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.06346-11","article-title":"Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences","volume":"86","author":"Misasi","year":"2012","journal-title":"J. Virol."},{"issue":"7\u20138","key":"10.1016\/j.antiviral.2018.07.003_bib27","first-page":"1305","article-title":"CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells","volume":"383","author":"Montaser","year":"2002","journal-title":"Biol. Chem."},{"issue":"9","key":"10.1016\/j.antiviral.2018.07.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.antiviral.2018.07.003_bib29","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O'Hearn","year":"2015","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.antiviral.2018.07.003_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.antiviral.2018.07.003_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","article-title":"Target identification and mode of action of four chemically divergent drugs against ebolavirus infection","volume":"61","author":"Ren","year":"2018","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.antiviral.2018.07.003_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.antiviral.2018.07.003_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs","volume":"15","author":"Salata","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib34","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/JVI.01621-12","article-title":"Filoviruses utilize glycosaminoglycans for their attachment to target cells","volume":"87","author":"Salvador","year":"2013","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.antiviral.2018.07.003_bib35","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2018.07.003_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0889-8553(21)00047-9","article-title":"Control of gastric acid secretion. histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors","volume":"21","author":"Shamburek","year":"1992","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.antiviral.2018.07.003_bib37","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry","volume":"78","author":"Takada","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2018.07.003_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2018.07.003_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor niemann-pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.antiviral.2018.07.003_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J. Biomol. Screen."},{"issue":"7610","key":"10.1016\/j.antiviral.2018.07.003_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:55Z","timestamp":1759062415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"alternative-id":["S0166354218303012"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}